We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
AstraZeneca
AZN
$250B
| $523K | 0.06% |
3,654
+49
| +1% | +$7.21K |
|
177
Shopify
SHOP
$195B
| $522K | 0.06% |
8,077
+127
| +2% | +$7.18K |
|
178
Berkshire Hathaway Class A
BRK.A
$1.12T
| $518K | 0.06% |
1
| – | – |
|
179
Bristol-Myers Squibb
BMY
$132B
| $504K | 0.05% |
7,878
-725
| -8% | -$48.6K |
|
180
Arista Networks
ANET
$238B
| $502K | 0.05% |
12,384
-4
| -0% | -$155 |
|
181
Hershey
HSY
$36.6B
| $495K | 0.05% |
1,984
+14
| +0.7% | +$3.67K |
|
182
Union Pacific
UNP
$174B
| $488K | 0.05% |
2,383
-222
| -9% | -$44.1K |
|
183
Mondelez International
MDLZ
$79.9B
| $487K | 0.05% |
6,683
+22
| +0.3% | +$1.63K |
|
184
Yum! Brands
YUM
$41.1B
| $485K | 0.05% |
3,504
+237
| +7% | +$32.1K |
|
185
Cincinnati Financial
CINF
$27.1B
| $479K | 0.05% |
4,926
-49
| -1% | -$5.06K |
|
186
Novartis
NVS
$297B
| $474K | 0.05% |
4,699
-63
| -1% | -$6.3K |
|
187
AT&T
T
$163B
| $472K | 0.05% |
29,604
-7,176
| -20% | -$122K |
|
188
Parker-Hannifin
PH
$135B
| $468K | 0.05% |
1,201
+6
| +0.5% | +$2.03K |
|
189
ConocoPhillips
COP
$141B
| $468K | 0.05% |
4,521
+194
| +4% | +$19.9K |
|
190
Cummins
CMI
$88.7B
| $468K | 0.05% |
1,910
-80
| -4% | -$18.1K |
|
191
FedEx
FDX
$75.4B
| $463K | 0.05% |
1,867
-8
| -0.4% | -$1.83K |
|
192
Otis Worldwide
OTIS
$28.2B
| $461K | 0.05% |
5,181
-193
| -4% | -$16.3K |
|
193
Qualcomm
QCOM
$176B
| $460K | 0.05% |
3,867
-335
| -8% | -$38.5K |
|
194
SPDR Gold Trust
GLD
$141B
| $447K | 0.05% |
2,505
| – | – |
|
195
Synopsys
SNPS
$79.7B
| $433K | 0.05% |
995
+12
| +1% | +$4.83K |
|
196
HCA Healthcare
HCA
$89.5B
| $431K | 0.05% |
1,421
-1
| -0.1% | -$278 |
|
197
Morgan Stanley
MS
$340B
| $431K | 0.05% |
5,043
-48
| -0.9% | -$4.11K |
|
198
CVS Health
CVS
$122B
| $430K | 0.05% |
6,217
-851
| -12% | -$60.6K |
|
199
Capital One
COF
$134B
| $425K | 0.05% |
3,890
+304
| +8% | +$30.4K |
|
200
iShares MSCI KLD 400 Social ETF
DSI
$5.55B
| $425K | 0.05% |
5,049
-150
| -3% | -$11.9K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.